GSK1733953A can be used as a small molecule Mycobacterium tuberculosis respiration inhibitor with an inhibitory effect on MenG activity and an IC50 value of 2.6 ± 0.6 uM.GSK1733953A is a selective biphenylbenzamide with an inhibitory effect on the catalytic methylation of the Mycobacterium tuberculosis desmethylnaphthoquinone methyltransferase, and the MIC of GSK1733953A against Mycobacterium tuberculosis H4Rv was 8.37 ug/ml. MIC of 8.37 ug/ml and MIC of 1.2 to 9.6 ug/ml against drug-resistant strains.GSK1733953A is a candidate compound for the treatment of tuberculosis.